Sinphar Pharmaceutical Co., Ltd. (1734) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sinphar Pharmaceutical Co., Ltd. (1734:TWSE), powered by AI.

Current Price
$31.45
Sector
Healthcare
What is the Sinphar Pharmaceutical Co., Ltd. stock price forecast?

Sinphar Pharmaceutical Co., Ltd. is currently trading at $31.45. View real-time AI analysis on Alpha Lenz.

What is Sinphar Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Sinphar Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Sinphar Pharmaceutical Co., Ltd.'s P/E ratio?

View Sinphar Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.

Sinphar Pharmaceutical Co., Ltd.

TWSE · 1734
NT$31.45-0.05(-0.16%)
Ask about Sinphar Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sinphar Pharmaceutical Co., Ltd.'s ROE is 10.9%. Explore profitability and growth together.

Ask for details

Company Overview

Sinphar Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, renowned for its dedication to the development, manufacture, and distribution of a wide array of medicinal products. The company focuses on producing over-the-counter drugs, ethical medications, and active pharmaceutical ingredients, catering to a diverse healthcare market. Its product range extends to health supplements, adding a holistic approach to public wellness. Sinphar Pharmaceutical's operations are underpinned by robust research and development efforts, emphasizing innovation and quality in therapeutics. The company significantly contributes to the healthcare sector by enhancing treatment efficacy and safety through advanced technologies and rigorous quality controls. With a strong presence in both domestic and international markets, Sinphar Pharmaceutical Co., Ltd. plays a crucial role in meeting the growing demands for effective healthcare solutions. Its commitment to sustainable practices and continuous improvement in drug formulations makes it a vital player in the global pharmaceutical landscape.

CEOMr. Zhiwen Li
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$3.37BRevenue
0.00Shares Out
0Employees

Margins

43.21%Gross
20.46%EBITDA
12.36%Operating
11.91%Pre-Tax
10.51%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

5.68%Rev 3Yr
7.14%Rev 5Yr
28.21%Op Inc 3Yr
N/AOp Inc 5Yr
29.22%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

5.69%ROA
10.91%ROE
6.99%ROIC

Financial Health

NT$864.14MCash & Cash Equivalents
NT$1.57BNet Debt
65.62%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sinphar Pharmaceutical Co., Ltd. (ticker: 1734) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 31.45 with a P/E ratio of -x and P/B of -x.

ROE is 10.91% and operating margin is 12.36%. Annual revenue is $3.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sinphar Pharmaceutical Co., Ltd. (1734) Stock Forecast 2026 $31.45 — Price, Financials & Analyst Targets | Alpha Lenz